NCM·Healthcare·$54M·#519 / 520 in Healthcare

STSS Sharps Technology Inc.

6CRITICAL

CATEGORY BREAKDOWN

GROWTH0
QUALITY0
STABILITY2
VALUATION0
GOVERNANCE35

METRIC BREAKDOWN

Revenue Growth (YoY)

Year-over-year revenue growth rate

N/A
0

> 50% strong

Gross Margin

Revenue retained after direct costs

N/A
0

> 50% strong

Cash Runway

Months of cash at current burn rate

1 months
2

> 24 months ideal

Debt / Equity

Total debt relative to shareholder equity

188.5%
0

< 25% strong

Price / Sales

Market cap relative to trailing revenue

175.6x
0

< 3x strong

Rule of 40

Growth rate plus operating margin

N/A
0

> 40 excellent

Insider Ownership

Percentage of shares held by insiders

7.4%
52

> 20% strong

Share Dilution (12M)

Share count increase over last 12 months

+424616.6%
0

< 5% ideal

5 more metrics available

Unlock all 8 metrics, score history, watchlist, and side-by-side comparison.

Try Free for 30 Days

AI ANALYSIS REPORT

AI-GENERATED

BUSINESS SUMMARY

Sharps Technology Inc. (STSS) is a healthcare company trading on NCM with a market capitalization of $54M. The company currently carries a CRITICAL rating of 6/100, indicating severe fundamental weakness across most metrics. The fundamental profile shows unavailable growth data at N/A year-over-year, paired with unavailable margin data at N/A. The balance sheet shows high leverage that significantly increases financial risk, and the company has critically low cash runway, raising near-term dilution or solvency concerns.

VERDICT

STSS scores 6/100 — critical fundamental weaknesses across most metrics. The data suggests significant operational challenges that must be addressed before the investment case improves. This report is based on the latest available financial data and is intended as a starting point for research, not a buy or sell recommendation.

MARKET OPPORTUNITY

In the healthcare sector, cash runway and pipeline progress are critical metrics. Revenue quality depends on whether income comes from product sales, partnerships, or milestones. Sharps Technology Inc. operates with moderate insider ownership of 7.4%, which provides a signal about management's confidence in the company's direction. At a market cap of $54M, the company is very richly valued at over 20x price-to-sales, pricing in significant future growth at 175.6x P/S. The combination of these factors positions STSS as a higher-risk position that requires careful due diligence before considering an investment.

REVENUE QUALITY

Revenue growth stands at N/A year-over-year, which is below the typical small-cap growth rate. Gross margins of N/A are thin and may compress further under competitive pressure. Cash runway of 1 months is a concern and may require the company to raise capital in the near term.

COMPETITIVE ADVANTAGE

Evaluating Sharps Technology Inc.'s competitive position requires looking beyond the numbers. Insider ownership at 7.4% is relatively low, which may indicate that management's interests are less aligned with shareholders. The margin structure suggests the company operates in a competitive market where differentiation is harder to maintain. The ongoing share dilution is a concern, as it reduces existing shareholders' ownership stake over time. Investors should research the specific sources of competitive advantage — patents, customer switching costs, scale economies, or brand — that could protect margins over time.

GROWTH THESIS

STSS presents a speculative fundamental profile that requires a specific thesis to justify investment. The elevated 175.6x P/S ratio means significant growth is already priced in — execution must be strong to justify the premium. Key catalysts to watch include: revenue growth trajectory over the next 2-3 quarters, margin expansion or contraction, and any changes in insider buying or selling activity.

KEY RISKS

Execution risk is significant — many small-cap companies in this sector fail to transition from growth to profitability. The elevated debt-to-equity ratio of 189x increases financial risk and limits the company's flexibility to weather downturns or invest in growth. Limited cash runway of 1 months means the company may need to raise capital, potentially diluting existing shareholders. Ongoing share dilution of 424616.6% erodes per-share value and suggests the company relies on equity issuance for operations or compensation. As a micro-cap stock, liquidity risk is a factor — wider bid-ask spreads and lower trading volumes can amplify price moves. Small-cap stocks carry inherently higher risk than large-caps, including limited analyst coverage, lower institutional ownership, and higher sensitivity to market downturns. Always conduct thorough due diligence beyond quantitative metrics.

Full AI Report available

Unlock the complete analysis including market opportunity, revenue quality, competitive moat, growth thesis, and risk assessment.

Try Free for 30 Days

Report generated: Mar 26, 2026

SCORE HISTORY

Track how this score changes over time. Start your free trial to see the full score trend chart.

SCORE ALERT

Get notified when STSS's score changes by 5+ points.

DATA INFO

Last updated: Mar 11, 2026

Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.